Menu
  • Home
  • USR Costa de Ponent

USR Costa de Ponent

RESPONSABLE
Betlem Salvador preguntant
Betlem Salvador Gonzalez
bsalvador.apms.ics@gencat.cat
avatar_grups_recerca.png

Publications

How to eliminate hepatitis C between people who inject drugs in community services and prisons in Catalonia

E. YELA, D. ABIÉTAR and R. CLUA-GARCÍA
Harm Reduction Journal. 2025 Jul 31; . doi:10.1186/s12954-025-01286-w; PMID:40745598

See more:
Insights on pediatric medication initiation: perceptions of caregivers and children

M. RUBIO-VALERA, C. CARBONELL-DUACASTELLA, M. PEÑARRUBIA-MARÍA, E. PACHECO, P. GABRIELA-RICCIARDELI, I. AZNAR-LOU and M. GIL-GIRBAU
Frontiers in Pharmacology. 2025 Jun 6; . doi:10.3389/fphar.2025.1612169; PMID:40548053

See more:
Estimating medication duration using EHR without knowing the prescribed dose: A case with benzodiazepines

I. AZNAR-LOU, M. PEÑARRUBIA-MARÍA, M. GARCÍA and L. PARKER
International Journal of Clinical Pharmacy. 2024 Feb 1;

See more:
Factors influencing initiation of treatments in the paediatric population: a qualitative study

M. RUBIO-VALERA, C. CARBONELL-DUACASTELLA, M. PEÑARRUBIÁ-MARIA, E. NAVAS, P. RICCIARDELLI, I. AZNAR-LOU and M. GIL-GIRBAU
International Journal of Clinical Pharmacy. 2024 Feb 1;

See more:
Cardiovascular disease and diabetes treatments: mixed-methods process evaluation (the IMA-cRCT study)

C. CORRAL-PARTEARROYO, A. SÁNCHEZ-VIÑAS, M. GIL-GIRBAU, I. AZNAR-LOU, M. PENARRUBIA-MARÍA, C. GALLARDO-GONZÁLEZ, M. OLMOS-PALENZUELA and M. RUBIO-VALERA
International Journal of Clinical Pharmacy. 2024 Feb 1;

See more:

Board of Trustees

Collaborators

Accreditations